Diabetic cardiomyopathy - The search for a unifying hypothesis

被引:476
作者
Poornima, IG
Parikh, P
Shannon, RP
机构
[1] Allegheny Gen Hosp, Dept Med, Pittsburgh, PA 15212 USA
[2] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
关键词
insulin resistance; diabetic cardiomyopathy; diastolic function; cardiac hypertrophy;
D O I
10.1161/01.RES.0000207406.94146.c2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although diabetes is recognized as a potent and prevalent risk factor for ischemic heart disease, less is known as to whether diabetes causes an altered cardiac phenotype independent of coronary atherosclerosis. Left ventricular systolic and diastolic dysfunction, left ventricular hypertrophy, and alterations in the coronary microcirculation have all been observed, although not consistently, in diabetic cardiomyopathy and are not fully explained by the cellular effects of hyperglycemia alone. The recent recognition that diabetes involves more than abnormal glucose homeostasis provides important new opportunities to examine and understand the impact of complex metabolic disturbances on cardiac structure and function.
引用
收藏
页码:596 / 605
页数:10
相关论文
共 98 条
  • [1] Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats
    Abe, T
    Ohga, Y
    Tabayashi, N
    Kobayashi, S
    Sakata, S
    Misawa, H
    Tsuji, T
    Kohzuki, H
    Suga, H
    Taniguchi, S
    Takaki, M
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 282 (01): : H138 - H148
  • [2] Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: A short review
    Adeghate, E
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2004, 261 (1-2) : 187 - 191
  • [3] Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis
    Atkinson, LL
    Fischer, MA
    Lopaschuk, GD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (33) : 29424 - 29430
  • [4] Diabetic cardiomyopathy: A metabolic perspective
    Avogaro, A
    de Kreutzenberg, SV
    Negut, C
    Tiengo, A
    Scognamiglio, R
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (8A) : 13A - 16A
  • [5] Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice
    Barouch, LA
    Berkowitz, DE
    Harrison, RW
    O'Donnell, CP
    Hare, JM
    [J]. CIRCULATION, 2003, 108 (06) : 754 - 759
  • [6] Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice
    Belke, DD
    Larsen, TS
    Gibbs, EM
    Severson, DL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 279 (05): : E1104 - E1113
  • [7] Diabetes and idiopathic cardiomyopathy - A nationwide case-control study
    Bertoni, AG
    Tsai, A
    Kasper, EK
    Brancati, FL
    [J]. DIABETES CARE, 2003, 26 (10) : 2791 - 2795
  • [8] Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium release channels
    Bidasee, KR
    Nallani, K
    Yu, YQ
    Cocklin, RR
    Zhang, YN
    Wang, M
    Dincer, ÜD
    Besch, HR
    [J]. DIABETES, 2003, 52 (07) : 1825 - 1836
  • [9] Turning down insulin signaling
    Birnbaum, MJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (05) : 655 - 659
  • [10] Ten years of protein kinase B signalling: a hard Akt to follow
    Brazil, DP
    Hemmings, BA
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2001, 26 (11) : 657 - 664